Investing.com - Purple Biotech ADR reported on Tuesday fourth quarter earnings that matched analysts' forecasts and revenue that was inline with expectations.
Purple Biotech ADR announced earnings per share of $-0.01 on revenue of $2.3M (NYSE:MMM). Analysts polled by Investing.com anticipated EPS of $-0.01 on revenue of $2.3M.
Purple Biotech ADR shares are up 17.32% from the beginning of the year and are trading at $4.470 , down-from-52-week-high.They are outperforming the Nasdaq which is up 4.7% from the start of the year.
Purple Biotech ADR shares lost 5.89% in intra-day trade the report.
Purple Biotech ADR follows other major sector earnings this month
Purple Biotech ADR's report follows an earnings beat by Ping An Insurance Company of China on February 3, who reported EPS of $0.6308 on revenue of $26.15B, compared to forecasts EPS of $0.6304 on revenue of $24.08B.
SoftBank Group had beat expectations on February 8 with fourth quarter EPS of $2.97 on revenue of $14.41B, compared to forecast for EPS of $0.0374 on revenue of $12.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar